Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|January 14, 2012
A potential relationship between diffuse musculoskeletal pain and hypogonadismJaclyn K Anderson, Rebecca Tuetken, Valerie Hoffman
Rheumatology (Oxford, England)|April 8, 2017
Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over timeXenofon Baraliakos, Joachim Sieper, Su Chen, et al.
Clinical and Translational Science|August 31, 2021
Upadacitinib pharmacokinetics and exposure-response analyses of efficacy and safety in psoriatic arthritis patients - Analyses of phase III clinical trialsElena Muensterman, Benjamin Engelhardt, Sathej Gopalakrishnan, et al.
RMD Open|June 28, 2019
Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 studyJoachim Sieper, Robert Landewé, Marina Magrey, et al.
Arthritis Care & Research|February 27, 2020
Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different DiseasesDirk Elewaut, Jürgen Braun, Jaclyn K Anderson, et al.
Arthritis Care & Research|July 31, 2015
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related ArthritisRubén Burgos-Vargas, Shirley M L Tse, Gerd Horneff, et al.
Arthritis Research & Therapy|March 29, 2018
Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trialDésirée van der Heijde, Joachim Sieper, Walter P Maksymowych, et al.
RMD Open|December 12, 2017
Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trialPhilip J Mease, Arthur Kavanaugh, Laura C Coates, et al.
The Journal of Pediatrics|July 29, 2018
Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn's DiseaseGerd Horneff, Marieke M B Seyger, Dilek Arikan, et al.
Rheumatology (Oxford, England)|December 5, 2021
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritisPeter Nash, Pascal Richette, Laure Gossec, et al.
Pageof 2